Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Acta Neurologica Scandinavica|October 7, 2009
Leptin and the metabolic syndrome in patients with myotonic dystrophy type 1V Rakocevic Stojanovic, S Peric, D Lavrnic, et al.Human Antibodies|May 20, 1999
Human monoclonal IgM DJ binds to ssDNA and human commensal bacteriaL A Dimitrijević, M I Radulović, B P Cirić, et al.Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|April 15, 2009
Hereditary motor and sensory neuropathy Lom type in a Serbian familyJ Dacković, M Keckarević-Marković, Z Komazec, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 19, 2005
The features of myasthenia gravis with autoantibodies to MuSKD Lavrnic, M Losen, A Vujic, et al.Acta Neurologica Scandinavica|September 9, 1999
Epidemiological and clinical characteristics of myasthenia gravis in Belgrade, Yugoslavia (1983-1992)D Lavrnić, M Jarebinski, V Rakocević-Stojanović, et al.European Neurology|January 1, 1995
Motor neuron disease and monoclonal gammopathyD Lavrnić, A Vidaković, V Miletić, et al.European Journal of Neurology|April 21, 2010
Guidelines for treatment of autoimmune neuromuscular transmission disordersG O Skeie, S Apostolski, A Evoli, et al.Annals of Neurology|December 1, 1993
The gp120 glycoprotein of human immunodeficiency virus type 1 binds to sensory ganglion neuronsS Apostolski, T McAlarney, A Quattrini, et al.Journal of Neuroscience Research|June 1, 1994
Identification of Gal(beta 1-3)GalNAc bearing glycoproteins at the nodes of Ranvier in peripheral nerveS Apostolski, S A Sadiq, A Hays, et al.European Journal of Neurology|September 18, 2008
EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseasesI Elovaara, S Apostolski, P van Doorn, et al.Pageof 6